Eurepa MF 1mg Tablet 10s
₹214.65
Estimate Delivery by -
EUREPA MF 1MG TABLET is a combination of Repaglinide and Metformin which belongs to the group of medicines called Anti-diabetic agents. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are already managed with Meglitinide and Metformin or who have inadequate glycemic control on a Meglitinide alone or Metformin.
During course of the management your doctor might regularly monitor your blood glucose level and kidney function test at regular intervals to avoid any untoward side effects. Avoid consumption of alcohol while taking EUREPA MF 1MG TABLET.
EUREPA MF 1MG TABLET is not recommended for use in patients with cardiac, kidney or respiratory failure, impaired liver or kidney function, diabetic ketoacidosis, type-1 diabetes mellitus and if you are dehydrated. Before taking EUREPA MF 1MG TABLET, inform your doctor if you have any planned major surgery.
EUREPA MF 1MG TABLET should not be used in pregnant women and breastfeeding women. This medicine is not recommended for use in children and adolescents (aged below 18 years) and it should be used with caution in elderly patients (aged 65 years and above).
The most common side effect of taking EUREPA MF 1MG TABLET are diarrhea, nausea, vomiting, stomach pain and taste disturbances. Consult your doctor if any of the side effects worsen.
Uses:
- Manage type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control
Directions of Use
Take EUREPA MF 1MG TABLET as advised by your physician. Swallow the medicine with a glass of water immediately before or up to 30 minutes before the meal. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
